A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo

NCT04818346 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

NonSegmental Vitiligo

Interventions

DRUG: INCB054707
DRUG: Placebo

Sponsor

Incyte Corporation